Patent Assignment
Reel/Frame 043305/0542
Assignment of Assignor's Interest
Recorded: 2017-08-16
Pages: 3
Assignor
SUMITOMO DAINIPPON PHARMA CO., LTD.
Executed: 2017-07-04
Assignee
INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
13-9, ENOKI-CHO, SUITA-SHI, OSAKA, 564-0053, JAPAN
Covered Properties
(3)
Hla-A24-Restricted Cancer Antigen Peptides
WT1 Substitution Pepides
Hla-A24-Restricted Cancer Antigen Peptides
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2004
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 016619/0189 →
Assignment of Assignor's Interest
Mar 18, 2005
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO; SAMIZO, FUMIO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 016836/0856 →
Merger
Dec 28, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017149/0949 →
Assignment of Assignor's Interest
Aug 29, 2006
From: SUGIYAMA, HARUO
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 018192/0210 →
Corrected Form Pto-1595 Correct Assignees #2 and #
Dec 13, 2006
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO; SAMIZO, FUMIO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 018704/0620 →
Change of Name
Oct 10, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033969/0194 →
Assignment of Assignor's Interest
Apr 25, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 038364/0495 →